Blood test trial aims to outsmart Cancer's evolution
NCT ID NCT04258137
Summary
This study is testing whether regularly checking for cancer DNA in the blood (a 'liquid biopsy') can help doctors better manage treatment for advanced colorectal or lung cancer. Patients will have their tumor's genetics analyzed, and a team of experts will recommend a treatment plan. Some patients will then have their treatment monitored with standard scans, while others will get both scans and regular blood tests to track cancer DNA, to see if this extra information helps improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHRU Brest
RECRUITINGBrest, 29200, France
Contact Email: •••••@•••••
Contact
-
Centre hospitalier de la Côte Basque
RECRUITINGBayonne, 64109, France
Contact Email: •••••@•••••
Contact
-
Clinique Tivoli-Ducos
RECRUITINGBordeaux, 33000, France
Contact Email: •••••@•••••
Contact
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
Contact Email: •••••@•••••
Contact
-
Polyclinique Bordeaux Nord Aquitaine
RECRUITINGBordeaux, 33077, France
Contact Email: •••••@•••••
Contact
-
Polyclinique Marzet
RECRUITINGPau, 64000, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.